Long-Term Investment or Short-Term? Enbridge Inc (ENB), Histogenics Corporation (HSGX)

0

The shares of Enbridge Inc (NYSE:ENB) and Histogenics Corporation (NASDAQ:HSGX) were among the active stocks of the last trading sessions. Enbridge Inc (NYSE:ENB) declined to -2.54% closing at the price of $31.84 whereas the shares of Histogenics Corporation (NASDAQ:HSGX) declined -3.44% with the decrease of -0.02 points closing at the price of $0.5. Enbridge Inc has currently decrease -0.69% in its stock over the period of 6-months while its rival Histogenics Corporation subtracted -82.57% in the previous 6-months.

Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.

Returns and Profitability

Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.

The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Enbridge Inc (NYSE:ENB) is 1.9% while the ROI of Histogenics Corporation (NASDAQ:HSGX) is 0%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, ENB’s EBITDA Margin is 15.97 whereas HSGX’s is -0.36.

Both the profitability ratios suggest that Enbridge Inc (NYSE:ENB) is more suitable investment in terms of profitability and return.

EPS & Surprise Factor

Enbridge Inc (NYSE:ENB) reported $0.31/share EPS for the previous quarter where analysts were predicting an EPS to be $0.37/share Thus lagging the analyst Estimates with a Surprise Factor of -16.2 Percent. While, Histogenics Corporation (NASDAQ:HSGX) reported EPS of $-0.13/share in the last quarter. The analysts projected EPS of $-0.23/share depicting a Surprise of 43.5 Percent.

Taking a look at Earnings per Share, Histogenics Corporation tends to be beating the analyst estimates more than Enbridge Inc. so HSGX is more profitable than ENB.

Technical Analysis of Enbridge Inc & Histogenics Corporation

Moving average convergence divergence (MACD) shows that Enbridge Inc (NYSE:ENB) is on a PRICE RELATIVITY trend While Histogenics Corporation (NASDAQ:HSGX) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Enbridge Inc was in BEARISH territory and Histogenics Corporation was in BEARISH territory.

ENB’s current statistics gauge that the stock candle is BEARISH with HIGH volatility. While HSGX’s candle is BEARISH with HIGH.

EPS Growth Rate: ENB’s 0.93% versus HSGX’s 0%

Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Enbridge Inc (NYSE:ENB) is predicted at 0.93% while Histogenics Corporation (NASDAQ:HSGX) stands at 0%. These numbers suggest that ENB is more suitable investment in terms of EPS growth rate.

Financial Risk and Liquidity Concerns

The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of ENB stands at 0.6 while HSGX is at 0.8 whereas the debt ratio of the prior is 1.21 while the debt ratio of the later is 0.

The values of the both ratios suggest that one is more liquid and other investment is more risk free.

Analyst Recommendations

While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.3 for ENB and 2.2 for HSGX which means ENB has Hold rating whereas HSGX has Hold rating.

Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for ENB is $45.03 which is 29.29% of its current price while HSGX has price target of 3.4 which is 85.29% of its current price.

Valuation Ratios

Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.

ENB currently has price to earning P/E ratio of 163.28 whereas HSGX has 0 while the forward P/E ratio for the prior stands at 16.84 and for the later it depicts the value of 0.

The price to Book P/B for ENB is 1.28, Price to Sale is at 1.56 and for HSGX these ratios stand at 0 and 0.